Cardiovascular Emergencies I updated 2013
Download
Report
Transcript Cardiovascular Emergencies I updated 2013
Assessment
Primary survey/
resuscitation
Secondary survey
Factors For Consideration
Unmodifiable
• Age
• Sex
• Heredity
• Race
Modifiable
• B/P
• Obesity
• Dyslipidemia
• Smoking
• Sedentary life
style
• Stress
• Diabetes
Subjective data
Chief complaint
History of present illness
•
•
•
•
•
•
•
Onset: OPQRST
Pain: PQRST
Provocation
Quality
Region/radiation
Severity
Time
Duration
Development over time
Periodicity (? Comes/goes)
Focused
Survey
Focused Survey
(Continued)
Dyspnea
• SOB
Dyspnea on
exertion
Positional dyspnea
• Paroxysmal
nocturnal dyspnea
• Orthopnea
Cough
Dry, “cardiac” cough
Hemoptysis
Syncope
Palpitations
Fatigue Nausea and
Vomiting
Headache
Behavioral change
Activity limitations
Injury: mechanism and
time
Medical History
Coronary Heart Disease
•
•
•
•
Angina
Previous MI
Hypertension
CHF
Pulmonary Disease
Diabetes
Renal Disease
Previous Cardiac
Surgery
Congenital Anomalies
Allergies
Current/Past Medication Use
Nitrates
Beta Blockers
Calcium
Channel
Blockers
Antihypertensives
Digitalis
Diuretics
Antidysrhythmics
Anticoagulants
Steroids
Specific
Pulmonary Drugs
Illicit Drugs
OVC Medications
Physical Exam
General Survey
• LOC
• Respiratory status
Rate, regularity, effort,
breath sounds
• Skin
Color, temperature,
moisture, capillary refill
• Edema
Dependent, extremities,
sacrum, pleural effusion,
ascitis, cardiac (pitting)
Physical Exam
Cyanosis
• Central
• Peripheral
Clubbing
B/P
Measurement
• Both arms
• Orthostatic
(supine, sitting,
standing)
0 = absent
1 = thready
2 = normal
3 = bounding
Apical heart rate
• Regular, irregular,
regularly irregular,
irregular irregular
Peripheral pulses
Pupils
• Size, equality,
reactive
Physical Exam
Inspection
Tracheal position
Neck veins
Thorax
• Configuration
Deformities, anterior,
posterior, A-P diameter,
symmetrical movement
Injuries, penetrating, blunt (ecchymosis,
contusions) evidence of scars, surgery
Abnormal chest movement,
asymmetrical, paradoxical
Physical Exam (Inspection)
Precordium
• Apical pulse
• Abnormal precordial
movements, heaves,
lifts, pulsations,
retractions
• Epigastrium,
pulsations
Physical Exam: Palpation
Areas tender, or
crepitus
Epigastrium
Physical Exam: Auscultation
Auscultatory sites
• Murmurs: systolic/diastolic
• Variations in rhythm
• Extra sounds
Pericardial friction rub
Venous hum
Arterial bruits
• Clicks
Physical Exam:
Diagnostic Procedures
ECG, 12 lead
• Rate, rhythm
• Presence of cardiac
dysrhythmias
• Evidence of myocardial
ischemia, injury
• Presence of
intraventricular
conduction defect
• Evidence of previous MI
CBC
Serum electrolytes
Cardiac serum markers
• Troponin
• Basic metabolic profile
• Coagulation studies
• Digoxin level
• Serum creatinine, BUN
• T& C
• ABGs
• Routine urinalysis
Physical Exam:
Diagnostic
Procedures
Comparison of Diagnostic Markers
Marker
Time from
Obstruction
Appears
CK-MB
Specifi
c to
Cardiac
Specific
to AMI
Disappears
6 hours 36 hours
Yes
Yes
Myoglobin 2 hours 24 hours
No
No
Troponin I 2 hours 1 week
Yes
No
Diagnostic
Procedures
Pulse oximetry
Radiography
• Chest x-ray
Heart size and
location
Presence of edema
Pulmonary infiltrates
Pleural effusions
Air and fluid levels in
trauma patients
Mediastinal width
Bony structure
integrity
Cardiac catheterization
Echocardiogram
Interventions
Determine priorities
• Airway, vital signs, cardiac rhythm, ABGs, Pulse
oximetry,
• Control pain
• Relieve anxiety
• Education patient/other
• Prevent complications
Establish care plan
Emergency equipment
Initiate appropriate interventions
Document data
Monitor responses and adjust
Pediatrics
Growth & Development
• R/T congenital heart disease
(heart defects)
• Acquired heart disease (rheumatic
fever)
• Endocrine (diabetes)
• Other
Drug ingestions, ex: tricyclics,
digoxin
Trauma (falls, MVCs)
Suffocation (plastic bags,
drowning, accidental hanging)
Pediatric
Pearls:
• Cardiac arrest usually d/t
progressive deterioration
in respiratory and heart
function
• CHF, cardiogenic shock,
dysrhythmias are unusual.
If occur congenital.
• Immature conduction
system and autonomic
innervation may
contribute to dysrhythmias
Geriatric
Presence of chronic
diseases
Altered drug metabolism
Multiple physiological
differences and changes
in lab values must be
considered when
assessing the older
patient
Psychological and social
changes: patient may
have different goals for
their treatment, discuss
with patient
Geriatric patients can
adapt to disease so
well that symptoms
are not obvious
Arteriosclerotic
changes in aorta and
peripheral pulses may
pose a difficulty in
palpating
Rhythm abnormalities
are so common that
they may be “normal”
Pearls
“Go slow, stay low”
with medications
Concurrent use of
other medications
cause problems,
• Easy to use meds
are helpful
(transdermals)
• One time or two time
doses daily
• Evaluate medications
on a frequent basis
Angina
Stable
• Symptom of
ischemia
• “pain or
discomfort”
• Poorly localized
• Flow/Demand
imbalance
• May be chronic,
acute, or
unstable
Angina (continued)
Unstable angina
• New symptoms of
angina
• Increasing symptoms
that occur at rest or
with on exertion
• Usually due to platelet
aggregation
• Leads to atypical
chest pain
Angina (Continued)
Unstable angina
diagnosis
• Angina is at rest, as well as
minimal exertion (usually
20 minutes or longer)
• Angina of new onset
(several weeks), starting
with physical exertion, and
markedly limits activity
• Previously diagnosed
stable angina
Normal ECG
Abnormal ECG Same Patient, Inverted T Waves
Angina cont’d
Variant Angina
• May or may not be due to
atherotic changes
• Thought to be due to coronary
spasm
• Prinzmetal’s angina
• May occur at the same time,
daily
• Usually not associated with
exertion or stress
• Occurs at younger ages
• ST elevation seen during pain,
then disappears
Angina: Curveballs
GERDs
Biliary Colic
Chest Wall Pain
Pericarditis
PE
Aortic Dissection
Dysrhythmias
Diagnostic Procedures: ECG
ST depression may accompany
pain with stable angina
Transient ST-segment
deviations (depression or
elevation), and T wave
inversion occur commonly with
unstable angina
Variant angina: ST elevation
occurs with pain, subsides
when pain does
May see LV hypertrophy, old
MI, nonspecific ST and T-wave
abnormalities and AV defects
Diagnostic Procedures
(Continued)
CBC
Cardiac serum
markers…no
elevation should
occur unless cell
damage
Chest X-ray (
CHF,
cardiomegaly)
Interventions
Continuous
monitoring
O2
IV, Draw labs
12 Lead ECG
Rest
Decrease anxiety
SL NTG, B/P 100 mm
HG followed by a drip
• Assess for H/A
• Reflex tachycardia
• Cautious with
elderly
Interventions (continued)
Beta blockers
• If clinical situation
deteriorates after B
Blocker, consider
coronary artery spasm
• Assess for signs of
heart failure
• Adverse effects of
blockers are
considered more
common and severe in
geriatric
Interventions (continued)
Administer antiplatelet
agents
• ASA (4-5 baby aspirin)
• Administer ASAP
• Decreases platelet
activation and thrombus
formation
TEACH/EDUCATION
Acute Myocardial Infarction
Myocardial
Infarction
(MI)Coronary
Occlusion
Heart
Attack
MI: Data
Physical exam
General appearance: Anxious, restless,
clenched fist against chest (Levine sign) Look
of doom
Heart rate: may be ok, tachycardia (most
common), bradycardia (inferior and RV),
Regular or irregular PVCs common
Data (continued)
Arterial BP
• Majority of patients with
uncomplicated MI are
normotensive
• May be elevated due to SNS
stimulation
Pain and anxiety
• Decreased as a result of impaired
cardiac function or due to drug
administration (nitrates, M.S.)
Data (continued)
Respiratory rate:
Initially elevated.
Should return to
normal after pain
relief
• Patients with CHF,
respiratory rate
correlates with
severity of condition
Data (continued)
Peripheral: How bad is the patient’s condition?
• Pallor, cyanosis, diaphoreses, mottled, cool,
peripheral pulses variable
Temperature: Often increases 4-8 hours post MI
Heart Sounds: muffled. murmurs may be transient
or permanent
Diagnosis
Continuous cardiac monitoring
12 lead ECG
Determine Location of infarct
(next slide)
Anterior Septal
ST
Leads 1, AVR,
V1 through V4
Lateral Apical
ST
Leads 1, AVL
V5 and V6
Posterior
Recipical Changes
V1,V2
No Q waves, Tall R’s
St
II,III,AVF
Upright t wave
ST
Leads II, III, AVF
Inferior
Serum Markers
Myoglobin
• Elevated 1-4 hours after onset of
MI, peaks 6-7 hours, normal in
about 1 day
• Lacks specificity, found in skeletal
muscle
Serum Markers
(continued)
Troponins:
• Most recent marker, most
sensitive and specific for
cardiac damage
• Elevated 3-12 hours after
MI, Peaks in 24 hours,
with TnI , returns to normal
in 5-12 days
• TnT may be elevated in
patients with renal failure,
which is not the case with
TnI; therefore TnI is
utilized.
Interventions
ABCs
Oxygen
IV or topical NTG, as B/P tolerated (B/P
100 or greater
IV with normal saline, KVO
Analgesia: M/S
ASA
12 Lead ECG
Blood samples for analysis
Interventions (continued)
If appropriate consider PTCA
Follow ACLS Guidelines
Prepare for Thrombolytic
Therapy as appropriate
Administer aspirin, nitrates,
heparin, plavix, Integrillin,
Lopressor, Morphine,
antiarrhythmics
Interventions (continued)
Observe patient:
• Bleeding,
reperfusions
dysrhythmias
• Vital signs,
ventricular ectopy,
and other
dysrhythmias
• Heart and lung
sounds
• LOC
Interventions (continued)
Portable chest film
ACLS measures
Prepare for cath lab
Educate and explain
Allow visit from
significant other
Heart Failure & Cardiogenic
Pulmonary Edema
Clinical syndrome, can
occur from any heart
disease
Pediatric..usually due
to congenital heart
defects
Inability to discharge
contents
Inability to pump
enough blood to meet
metabolic needs
Diagnostics
Lab:
•
•
•
•
•
H& H
Lytes
BUN, Creatinine
Liver function studies
Cardiac enzymes (if
AMI)
• BNP
B-type natriuretic
peptide
Radiologic:
• often normal
• pulmonary vasculature,
edema, fluid
• Cardiac silhouette may
show cardiac
enlargement,
hypertrophy, dilation
• Enlarged RA and RV
• Pleural effusion
• Valve calcifications
Diagnostics cont’d
ECG: nonspecific changes, electrolyte or
drug induced dysrhythmias
Echo: chamber size,wall thickness,
thrombus formation, valvular function,
pericardial disease
Interventions
ABCD
Provide
supplemental O2
IV Normal Saline
ABGs and other labs
Provide rest
ECG continuous
Monitor
hemodynamics
Administer
Morphine
Administer
vasodilator
• Decreases
afterload, arterial
dilations. Also preload
Vasodilators (continued)
NTG, Isosorbide
• Increases
venous pooling
• NTG preferred
in pulmonary
edema, CAD
since improves
coronary artery
perfusion
• Venous dilation
Vasodilators (continued)
Diuretics:
• Decrease preload
• Foley catheter,
possible
• I&O
• Monitor serum K+
Vasodilators (continued)
ACE Inhibitors:
• Captopril, Enalapril
• Block formation of
Angiotensin II,
yields vasodilation
• Reduce mortality,
by improving
cardiac function
• Avoid overdiuresis
• Cleared by kidney
Hypertensive Emergencies
Life-threatening elevation of B/P necessitating
reduction to prevent end-organ damage and potential
death
Essential hypertension
• unknown cause
Secondary hypertension
• elevated pressure whose cause is known (renal vascular
disease)
Produces changes in arterioles (necrosis and
inflammation over time) causing decrease in
bloodflow to end organs
Accelerated and/or malignant
• hypertension:Diastolic pressure higher than 140 mmHg
Precipitating Factors
Untreated/uncontrolled essential or secondary
hypertension
Poor patient compliance with antihypertensive
medications
Renal dysfunction
Eclampsia of pregnancy (not tolerated well)
Adrenergic crises
AMI,
Cerebral dysfunction
Pituitary tumors
Assessment
History
Severe H/A
Epistaxis
Family hx hypertension
MAO inhibitors
CAD, Renal Disease
Diabetes, obesity, smoker,
hyperlidemia, stress
Exam
Diastolic pressure exceeding diastolic or
120mmHG
Retinopathy with exudates, Retinal hemorrhages
Papilloedema (diastolic pressure > 140)
H/A, confusion, restless stupor, somnolence
Epistaxis
Tachycardia
Chest discomfort
N&V
Rales
Oliguria, azotemia
Diagnostics
Lab:
• ABG:
metabolic acidosis
• CBC HCT
in renal failure,
polycythemia in renal
• Electrolytes:
Hypocalcemia
Hyponatremia
aldosteronism causes
hypokalemia ( half of
patients)
• Glucose: elevated in
Cushing’s Syndrome,
diabetes
• BUN and creatinine
elevated in renal
disease
• Uric acid: hyperuricemia in renal
failure
• U/A: proteinuria,
possible renal
dysfunction
Radiologic Findings
Chest film: cardiomegaly may be seen
ECG: LV hypertrophy may be seen
CT scan: Diffuse brain edema with hypertensive
crises
ECHO: diastolic function impaired.
Interventions
ABCD, O2, IV @ KVO rate
ACLS protocols
Administer medications
NTP:
• Most common and most effective
• 0.5-10mcg/kg/min
• Titrate with B/P
• Watch for cyanide toxicity
• Drug is light sensitive
Interventions (continued)
NTG:
• Drug of choice for unstable angina and
ischemia, LV failure, adrenergic crises
• Provides immediate response
Sympathetic Blocking Agent (Labetalol)
• Alpha and beta blocker
• Onset and cessation of action slower than
NTP and NTG
• Contraindicated in patients with heart
failure, greater than 1st degree block,
bradycardia, and reactive airway disease
Interventions (continued)
ACE Inhibitors
• Used in presence of LV failure
• Captopril: 6.25-50 mg orally every 30-45
minutes
• Enalapril: 1.25-5 mg IV every 6 hours
• Onset of action for both 10-15 minutes
Interventions (continued)
Calcium Channel Blockers
• Nifidipine: 10 mg PO or sublingual (10-20 mg
orally every 30-45 minutes of sublingually every
15 minutes)
Beta Blocker: Metoprolol, Esmolol
• Blocks effects of increased adrenergic tone
• Metoprolol 5 mg IV every 5 minutes up to 15 mg
total
Interventions (continued)
Administer diuretics
Closely monitor patient’s response
Continuous arterial monitoring
Watch medication side effects
Observe for signs of ischemia
I&O
Monitor for dysrhythmias
Monitor for ↑ ICP
Possible ICP monitoring
Sudden chest pain may suggest aortic dissection
Reassure patient/family Calm environment
Questions????????